Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-005622
Filing Date
2022-01-31
Accepted
2022-01-31 17:04:00
Documents
1
Period of Report
2022-01-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3974
  Complete submission text file 0001209191-22-005622.txt   5434
Mailing Address C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address
PICKERING GRANT (Reporting) CIK: 0001258693 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39503 | Film No.: 22574851

Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Issuer) CIK: 0001620463 (see all company filings)

EIN.: 453368487 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)